PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
113 hedge funds and large institutions have $2.02B invested in PhenomeX Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 46 increasing their positions, 10 reducing their positions, and 9 closing their positions.
411% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 9
360% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 10
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
110% more call options, than puts
Call options by funds: $7.58M | Put options by funds: $3.6M
52% more capital invested
Capital invested by funds: $1.32B → $2.02B (+$694M)
49% more funds holding
Funds holding: 76 → 113 (+37)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$116M |
| 2 |
FAM
Fred Alger Management
New York
|
+$64.1M |
| 3 |
CFM
Comprehensive Financial Management
Los Gatos,
California
|
+$48.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.6M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$22.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$19.6M |
| 2 |
Morgan Stanley
New York
|
-$15.4M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$8.11M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.29M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.04M |
CELL Hedge Fund Activity: Q4 2020 in Review
113 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q4 2020, worth a combined $2.02B — up 52% from $1.32B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new CELL positions and 9 closed out — a net gain of 37 holders — while 46 added to existing stakes and 10 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $116M. The largest seller was Ameriprise, cutting an estimated $19.6M.
- 113 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q4 2020, up from 76 in Q3 2020.
- Funds reported $2.02B of PhenomeX Inc. Common Stock stock for Q4 2020, up 52% quarter-over-quarter.
- 46 funds opened new PhenomeX Inc. Common Stock positions in Q4 2020 and 9 closed out, a net change of +37 holders.
- The largest PhenomeX Inc. Common Stock buyer in Q4 2020 was ARK Investment Management, an estimated $116M added.
- The largest PhenomeX Inc. Common Stock seller in Q4 2020 was Ameriprise, an estimated $19.6M sold.
Based on aggregated 13F filings for Q4 2020.